Chilton Capital Management Lowered Merck & Co (MRK) Position By $5.97 Million; Servisfirst Bancshares (SFBS) Sellers Increased By 11.72% Their Shorts

April 25, 2018 - By Henry Gaston

Merck & Co., Inc. (NYSE:MRK) Logo

Servisfirst Bancshares Inc (NASDAQ:SFBS) had an increase of 11.72% in short interest. SFBS’s SI was 2.62 million shares in April as released by FINRA. Its up 11.72% from 2.34M shares previously. With 182,700 avg volume, 14 days are for Servisfirst Bancshares Inc (NASDAQ:SFBS)’s short sellers to cover SFBS’s short positions. The SI to Servisfirst Bancshares Inc’s float is 5.79%. The stock increased 0.03% or $0.01 during the last trading session, reaching $43.33. About 37,759 shares traded. ServisFirst Bancshares, Inc. (NASDAQ:SFBS) has risen 15.16% since April 25, 2017 and is uptrending. It has outperformed by 3.61% the S&P500.

Chilton Capital Management Llc decreased Merck & Co Inc (MRK) stake by 63.02% reported in 2017Q4 SEC filing. Chilton Capital Management Llc sold 106,617 shares as Merck & Co Inc (MRK)’s stock declined 4.63%. The Chilton Capital Management Llc holds 62,571 shares with $3.52 million value, down from 169,188 last quarter. Merck & Co Inc now has $159.72B valuation. The stock decreased 1.29% or $0.78 during the last trading session, reaching $59.31. About 5.42 million shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 25, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 89 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) has “Overweight” rating given on Monday, September 21 by JP Morgan. On Tuesday, February 6 the stock rating was maintained by Leerink Swann with “Market Perform”. As per Thursday, April 5, the company rating was upgraded by Barclays Capital. The firm earned “Buy” rating on Tuesday, June 6 by BMO Capital Markets. The rating was maintained by Credit Suisse with “Neutral” on Monday, May 9. The firm has “Equal-Weight” rating by Barclays Capital given on Monday, October 30. As per Tuesday, June 14, the company rating was maintained by Jefferies. As per Monday, July 31, the company rating was maintained by UBS. Jefferies maintained it with “Hold” rating and $5500 target in Friday, March 23 report. Guggenheim maintained the shares of MRK in report on Tuesday, April 17 with “Buy” rating.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It dived, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Macguire Cheswick And Tuttle Inv Counsel holds 1.02% or 99,962 shares in its portfolio. Patten Group invested in 28,652 shares. Private Asset Mngmt Incorporated holds 2.1% or 234,570 shares in its portfolio. Pinnacle Assocs stated it has 0.58% in Merck & Co., Inc. (NYSE:MRK). Washington Capital Mngmt Inc has invested 1.92% in Merck & Co., Inc. (NYSE:MRK). Lvw Advsr Ltd Limited Liability Company invested 0.35% in Merck & Co., Inc. (NYSE:MRK). Bell Bank holds 0.07% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 4,186 shares. First Heartland Consultants holds 0.13% or 7,645 shares in its portfolio. Weiss Multi holds 0.04% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 25,000 shares. Connors Investor Serv has 157,131 shares for 1.27% of their portfolio. Professional Advisory holds 0.09% or 7,372 shares in its portfolio. United Cap Advisers Limited has 0.3% invested in Merck & Co., Inc. (NYSE:MRK) for 679,700 shares. Miller Howard Ny owns 1.44M shares or 1.76% of their US portfolio. Pictet North America reported 0.33% stake. Bingham Osborn & Scarborough Limited Liability Company stated it has 0.03% in Merck & Co., Inc. (NYSE:MRK).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on May, 1 before the open. They expect $0.99 earnings per share, up 12.50% or $0.11 from last year’s $0.88 per share. MRK’s profit will be $2.67B for 14.98 P/E if the $0.99 EPS becomes a reality. After $0.98 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts 1.02% EPS growth.

Chilton Capital Management Llc increased Ishares Inc (IEMG) stake by 7,555 shares to 13,830 valued at $787,000 in 2017Q4. It also upped Waste Mgmt Inc Del (NYSE:WM) stake by 45,606 shares and now owns 123,899 shares. Essex Ppty Tr Inc (NYSE:ESS) was raised too.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts